APA (7th ed.) Citation

A, M., C, J., N, P., ME, S., J, F., M, G., . . . R, G. (2022). Interlaboratory Analytical Validation of a Next-Generation Sequencing Strategy for Clonotypic Assessment and Minimal Residual Disease Monitoring in Multiple Myeloma. Archives of pathology & laboratory medicine, 146(7), 862. https://doi.org/10.5858/arpa.2021-0088-OA

Chicago Style (17th ed.) Citation

A, Medina, et al. "Interlaboratory Analytical Validation of a Next-Generation Sequencing Strategy for Clonotypic Assessment and Minimal Residual Disease Monitoring in Multiple Myeloma." Archives of Pathology & Laboratory Medicine 146, no. 7 (2022): 862. https://doi.org/10.5858/arpa.2021-0088-OA.

MLA (9th ed.) Citation

A, Medina, et al. "Interlaboratory Analytical Validation of a Next-Generation Sequencing Strategy for Clonotypic Assessment and Minimal Residual Disease Monitoring in Multiple Myeloma." Archives of Pathology & Laboratory Medicine, vol. 146, no. 7, 2022, p. 862, https://doi.org/10.5858/arpa.2021-0088-OA.